Physician profile
Jatinder Kumar
NPI 1811456866
$1,278.11
in general payments reported to CMS, 2019-2025
20 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $31.91 · 2023: $36.42 · 2024: $641 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $232.86 | 2024-2025 | Perclot, Floseal |
| Janssen Scientific Affairs, LLC | $142.81 | 2024 | Akeega, Erleada |
| Boston Scientific Corporation | $121.35 | 2021 | |
| Janssen Biotech, INC. | $100.75 | 2025 | Erleada |
| Sumitomo Pharma America, INC. | $88.48 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $84.78 | 2024 | Itind System, Bovie |
| Medtronic, INC. | $79.73 | 2024 | Interstim |
| Procept Biorobotics Corporation | $74.94 | 2025 | |
| Endo Pharmaceuticals INC. | $48.37 | 2024 | Xiaflex, Aveed |
| Endo USA, INC. | $47.06 | 2024-2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $44.38 | 2025 | |
| Myriad Genetic Laboratories, INC. | $35.89 | 2024-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $34.16 | 2024 | Provenge |
| Abbvie INC. | $33.53 | 2025 | |
| Novo Nordisk INC | $23.46 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $20.06 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $18.52 | 2022 | |
| Bluewind Medical | $18.04 | 2024 | Revi |
| Mission Pharmacal Company | $15.55 | 2024 | Uribel Tabs |
| Progenics Pharmaceuticals, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jatinder Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.